Elanco Animal Health Inc
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
ELAN$26.76-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | $428 | $545 |
| Accounts receivable, net | 1,084 | 873 |
| Other receivables | 70 | 67 |
| Inventories | 1,717 | 1,737 |
| Prepaid expenses and other | 285 | 236 |
| Total current assets | 3,584 | 3,458 |
| Noncurrent Assets | ||
| Property and equipment, net | 1,395 | 1,409 |
| Goodwill | 4,723 | 4,779 |
| Other intangibles, net | 3,225 | 3,408 |
| Other noncurrent assets | 295 | 304 |
| Total assets | $13,222 | $13,358 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Accounts payable | $372 | $368 |
| Sales rebates and discounts | 400 | 416 |
| Current portion of long-term debt and finance lease liability | 73 | 74 |
| Other current liabilities | 817 | 739 |
| Total current liabilities | 1,662 | 1,597 |
| Noncurrent Liabilities | ||
| Long-term debt and finance lease liability | 3,918 | 3,943 |
| Liability for sale of future revenue | 309 | 304 |
| Deferred taxes | 366 | 382 |
| Other noncurrent liabilities | 467 | 585 |
| Total liabilities | 6,722 | 6,811 |
| Commitments and Contingencies | ||
| Equity | ||
| Preferred stock, 1,000,000,000 shares authorized, no par value; none issued | — | — |
| Common stock, no par value, 5,000,000,000 shares authorized, 499,381,644 and 496,975,154 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | — | — |
| Additional paid-in capital | 8,858 | 8,870 |
| Accumulated deficit | (2,125) | (2,182) |
| Accumulated other comprehensive loss | (233) | (141) |
| Total equity | 6,500 | 6,547 |
| Total liabilities and equity | $13,222 | $13,358 |
2026 Q1 Form 10-Q | 6
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.